Cargando…
Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants
Tumor necrosis factor-alpha (TNF) binds to two receptors: TNFR1/p55-cytotoxic and TNFR2/p75-pro-survival. We have shown that tumor growth in p75 knockout (KO) mice was decreased more than 2-fold in Lewis lung carcinoma (LLCs). We hypothesized that selective blocking of TNFR2/p75 LLCs may sensitize t...
Autores principales: | Sasi, Sharath P., Bae, Sanggyu, Song, Jin, Perepletchikov, Aleksandr, Schneider, Douglas, Carrozza, Joseph, Yan, Xinhua, Kishore, Raj, Enderling, Heiko, Goukassian, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963887/ https://www.ncbi.nlm.nih.gov/pubmed/24664144 http://dx.doi.org/10.1371/journal.pone.0092373 |
Ejemplares similares
-
Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants
por: Sasi, Sharath P., et al.
Publicado: (2015) -
TNF-α and IL-1α but not MCP-1 and Rantes increase significantly the formation of p-H2AX foci in naïve BM-derived TNFR1/p55KO EPCs
por: Sasi, Sharath P., et al.
Publicado: (2014) -
BREAKING THE “HARMONY” OF TNF-α SIGNALING FOR CANCER TREATMENT
por: Sasi, Sharath P., et al.
Publicado: (2011) -
Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants
Publicado: (2014) -
Radiation-associated degenerative cardiovascular risks during normal aging and after adverse CV event 10 months post-initial exposure
por: Sasi, Sharath P., et al.
Publicado: (2014)